Table 1.
Participant demographics
Seropositive group (n=225) | Seronegative group (n=2851) | ||
---|---|---|---|
Mean age, years | 19·0 (1·8) | 19·1 (1·9) | |
Sex | |||
Female | 22 (10%) | 229 (8%) | |
Male | 203 (90%) | 2622 (92%) | |
Race | |||
Non-Hispanic White | 56 (25%) | 1698 (60%) | |
Non-Hispanic Black | 50 (22%) | 349 (12%) | |
Non-Hispanic Other | 7 (3%) | 183 (6%) | |
Hispanic | 112 (50%) | 621 (22%) | |
Non-US residence | |||
No | 216 (96%) | 2749 (96%) | |
Yes | 4 (2%) | 19 (1%) | |
N/A* | 5 (2%) | 83 (3%) | |
Non-US birth | |||
No | 189 (84%) | 2626 (92%) | |
Yes | 32 (14%) | 192 (7%) | |
N/A | 4 (2%) | 33 (1%) |
Data are n (%) or mean (SD). A total of 173 participants were excluded because they were lost to follow-up, did not have a valid baseline IgG, or became PCR positive during the quarantine period. The table includes all 3076 participants who entered training and were followed prospectively, including the 640 participants who were later excluded from further analysis (figure 1). N/A=not applicable.
If a participant answered unknown or left a question blank, then the value is grouped into N/A.